secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jasper Therapeutics, Inc. (JSPR)
CIK:        0001788028
Form:       8-K
Filed at:   2023-01-19T23:59:59+00:00
Accession:  0001213900-23-003597
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jasper Therapeutics regains Nasdaq minimum bid price compliance
---------------------------------------------------------------

- Received Nasdaq letter on Jan 18, 2023 confirming full compliance with Listing Rule 5550(a)(2).
- Closing bid price of voting common stock was $1.00 or higher for ten consecutive days (Jan 3-17, 2023).
- Compliance removes risk of delisting from Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1788028/000121390023003597/0001213900-23-003597-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1788028/000121390023003597/ea171850-8k_jasper.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-003597

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer